Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia (Q57704398)

1

A Benigni

0 references

Giuseppe Remuzzi

Giuseppe Remuzzi

6

0 references

Ariela Benigni

1

Ariela Benigni

0 references

Miriam Galbusera

3

Miriam Galbusera

0 references

author name string

P Boccardo

2

0 references

M Galbusera

3

0 references

J Monteagudo

4

0 references

L De Marco

5

0 references

Z M Ruggeri

7

0 references

Paola Boccardo

2

0 references

Juan Monteagudo

4

0 references

Luigi De Marco

5

0 references

Zaverio M. Ruggeri

American Journal of Kidney Diseases

7

0 references

language of work or name

English

0 references

publication date

November 1993

0 references

published in

0 references

volume

22

0 references

issue

5

0 references

page(s)

668-76

0 references

668-676

0 references

cites work

The bleeding disorder of uraemia. A qualitative platelet defect

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Hemostatic abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Platelet Function in Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Metabolism and function of human platelets washed by albumin density gradient separation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Platelets have more than one binding site for von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

THE PREPARATION AND SOME PROPERTIES OF FIBRINOGEN PRECIPITATED FROM HUMAN PLASMA BY GLYCINE

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Spectrum of von Willebrand's Disease: a study of 100 cases. Italian Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Hemodialysis-associated platelet activation and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Plasma and platelet von Willebrand factor defects in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Reduction of platelet glycoprotein Ib in uraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021

Bleeding in renal failure: a possible cause

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980429-X

7 January 2021